The FORMAMP project focus on innovative nanoformulation design of antimicrobial peptides

The long-term objective of the FORMAMP project is to significantly change the treatment strategies for infectious diseases and to reduce the drastic increase of resistant bacteria.

The project aims to develop new and innovative formulation strategies, based on the combination of nanotechnology-based delivery systems and antimicrobial peptides (AMPs), for the treatment of infectious diseases caused by bacteria such as Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus (MRSA), and Mycobacterium tuberculosis.

FORMAMP is funded by the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no 604182.

Latest news

FORMAMP Newsletter #3

FORMAMP newsletter June 2017_mini

With full speed ahead at the final stages of the project, FORMAMP has released its third newsletter with a fresh status update of project developments and developments within the antimicrobial resistance field.

Click here to download the newsletter (pdf)

Click here to subscribe to our upcoming newsletters

Latest tweets